SRI wins $150m grant to develop HIV prevention products
SRI International said today that it landed a $150 million contract from the National Institutes of Health‘s National Institute of Allergy and Infectious Diseases and the Division of AIDS to support...
View ArticleCytoSorbents gains on German reimbursement win
CytoSorbents Corp. (NSDQ:CTSO) shares jumped 9% to $5.35 apiece today after the company reported that it landed a permanent reimbursement procedure code for its CytoSorb therapy in Germany. The...
View ArticleMedtronic, Fitbit ink CGM and physical activity data integration deal
Medtronic (NYSE:MDT) said today it partnered with Fitbit to integrate CGM data alongside physical activity data in Medtronic’s iPro2 myLog mobile application. The partnership will allow type 2...
View ArticleAbbott files to terminate $6B Alere acquisition
Abbott (NYSE:ABT) said today it filed a complaint with the Delaware Court of Chancery seeking to terminate its proposed $5.8 billion acquisition of Alere (NYSE:ALR), referencing a “substantial loss in...
View ArticleMylan to cut 10% of workforce in restructuring efforts
Mylan (NSDQ:MYL) shares dropped 5% this morning after it said in regulatory filing that it expects to cut less than 10% of its global workforce as a result of its restructuring efforts. The...
View ArticleVarian to receive $200m from Varex Imaging spin-off
Varian Medical (NYSE:VAR) said today that it will receive $200 million from its imaging components spin-off Varex Imaging in January as part of an updated separation deal. The spin off will be a new,...
View ArticleFDA releases October 2016 510(k) clearances
510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD October 2016 TOTAL 510(k)s THIS PERIOD 235 TOTAL WITH SUMMARIES 223 TOTAL WITH STATEMENTS 12 DEVICE: EasyMap MAP...
View ArticleOne Drop wins FDA nod, CE Mark for mobile blood glucose monitor
One Drop said today that it won 510(k) clearance from the FDA and CE Mark clearance for its One Drop | Chrome blood glucose monitoring system. The system is a part of One Drop | Premium, which the...
View ArticleMassDevice.com +5 | The top 5 medtech stories for December 7, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleBaxter lays off 12 at Bloomington facilities
Baxter (NYSE:BAX) is laying off 12 employees from its Bloomington, Ind. facilities, according to a report from The Herald Times. The dismissals mark the 2nd round for the company at its Bloomington...
View ArticleU.S. Senate passes 21st Century Cures Act
The U.S. Senate voted 94-5 today to pass the 21st Century Cures Act, sending the measure to President Barack Obama, who is likely to sign it into law soon. The U.S. House voted to pass the healthcare...
View ArticleAerie completes enrollment of phase III trial for intraocular pressure eye drops
Aerie Pharmaceuticals (NSDQ:AERI) said today that it completed enrollment for its 2nd phase III registration trial, Mercury 2, evaluating its Roclatan once-daily eye drops for intraocular pressure...
View ArticleStudy finds medical skin glue can reduce IV drip failure
Researchers from the Caboolture Hospital in Queensland, Australia found that medical skin glue can be used to hold hospital intravenous lines in place, significantly reducing the risk of infection,...
View ArticleTerumo moves forward on $1B deal to pick up St. Jude, Abbott vascular assets
Terumo Corp. (TYO:4543) said today it reached an agreement with Abbott (NYSE:ABT) and St. Jude Medical (NYSE:STJ) to acquire vascular products from both companies in connection to their $25 billion...
View ArticleSanovas launches SinuGeniX sinus treatment subsidiary
Sanovas recently announced the launch of SinuGeniX, a wholly-owned subsidiary focused on treating chronic sinusitis with the company’s RegENT sinus treatment system. The newly-launched subsidiary won’t...
View ArticleFrom smart toothbrushes to cancer, Philips bets big on software
(Reuters) – These days the average researcher at Royal Philips (NYSE:PHG) is more likely to be a software developer than an product engineer, reflecting a transformation at the former Dutch...
View ArticleFDA releases November 2016 510(k) clearances
510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD November 2016 TOTAL 510(k)s THIS PERIOD 254 TOTAL WITH SUMMARIES 241 TOTAL WITH STATEMENTS 13 DEVICE: Quest...
View ArticleAcelity spikes $1B IPO
Wound care and regenerative medicine company Acelity yesterday spiked an initial public offering that could have fetched as much as $1 billion. Acelity, formerly Kinetic Concepts Inc., was acquired for...
View ArticleFDA takes steps to improve hearing aid accessibility
The U.S. Food and Drug Administration today announced important steps to better support consumer access to hearing aids. The agency issued a guidance document explaining that it does not intend to...
View ArticleResearchers use drug-loaded microneedles for transdermal delivery
Researchers from the Beijing University of Chemical Technology have developed a method to introduce a bubble-shaped microstructure into the base of drug-loaded dissolving microneedles for use as a...
View Article
More Pages to Explore .....